Yasuyama et al. (1988) found significantly higher plasma SOD activity in chronic hepatitis, autoimmune hepatitis, primary biliary cirrhosis and hepatocellular carcinoma groups than in the healthy control group. This evidence concerns the gene SOD1 and primary biliary cholangitis.